When we focused on the grade IV astrocytomas (GBMs) alone, which constitute the most aggressive and lethal subtype, 31% of the tumors demonstrated moderate to strong staining for TEM1/endosialin (Table 2). Here, CD248 is linked to astrocytoma (excluding glioblastoma).